Intellectual Property

Todd Lorenz is a counsel in the firm’s intellectual property practice group with twenty years of experience in life sciences intellectual property law.  His law practice encompasses strategic patent prosecution and counseling along with related due diligence, opinion work, licensing, and litigation, and he is known for bringing a practical business-oriented focus to the task of global patent portfolio management, working closely with his clients to ensure the filing and pursuit of commercially-relevant claims.  He advises universities, clinical research centers, and emerging and established life science companies on all aspects of domestic and international patent procurement and enforcement in a broad range of technical areas including biologics, pharmaceuticals, diagnostics, medical devices, and laboratory reagents and procedures along with related instrumentation.  As co-founder and executive chairman of Myocept Inc., a biotech start-up developing a new class of protein therapeutics, he is particularly attuned to the needs and challenges of emerging companies.

With an academic background in biology and engineering at Rensselaer Polytechnic Institute, clinical research experience in cancer immunotherapy at Harvard Medical School, and practical hands-on experience in drug development and formulation at Myocept Inc., Mr. Lorenz brings a wide range of technical capabilities throughout the biotechnology and pharmaceutical arts to his law practice.  Mr. Lorenz also has experience litigating patent, copyright, trademark, and trade secret cases before a number of state, federal, and appellate courts, including the District Courts in California and the US Court of Appeals for the Federal Circuit.

Intellectual Property Representative Matters

Litigation

• Eppendorf AG v. Bio-Rad Laboratories Inc.: Parallel patent infringement litigations in the Eastern District of Texas and Northern District of California involving injection-molded microtiter plate technology.
• Dionex Corporation v. Alltech, Inc.: Priority of invention dispute in Federal District Court in combination with interference proceeding before the USPTO involving liquid chromatography technology.
• Dolby Laboratories, Inc. v. Smart Devices Inc.: Trademark infringement and false advertising dispute involving sound enhancement technology.
• Hoffman La-Roche v. Promega Corporation: Patent infringement and breach of contract action involving thermostable polymerase enzymes and fundamental DNA amplification technology.

US Patents

• U.S. Patent No. 7,922,999: Administration of Growth Factors for the Treatment of CNS Disorders
• U.S. Patent No. 7,863,050: Methods and Compositions for Purification of Nucleic Acid from a Host Cell
• U.S. Patent No. 7,812,124: Profiling Tumor Specific Markers for the Diagnosis and Treatment of Neoplastic Disease
• U.S. Patent No. 7,744,893: T Cell Receptor CDR3 Sequences Associated with Multiple Sclerosis and Compositions Comprising Same
• U.S. Patent No. 7,528,240: Methods for Producing Anti-Thymocyte Immunoglobulins
• U.S. Patent No. 7,498,309: Pharmaceutical Compositions for Bioactive Peptide Agents
• U.S. Patent No. 7,416,887: Methods for Use of MPL Ligands with Primitive Human Stem Cells
• U.S. Patent Nos. 7,347,977 and 7,744,893: Microtitration Plate
• U.S. Patent No. 7,151,090: Methods for Enhancing Graft Survival by Modulating Heme Oxygenase Activity
• U.S. Patent Nos. 7,229,628; 6,051,227; 5,855,887 and 5,811,097: Blockade of T-Lymphocyte Down-Regulation Associated with CTLA-4 Signaling.
• U.S. Patent No. 7,094,413: Combined Therapy for Treatment of HIV Infection
• U.S. Patent Nos. 6,982,246 and 6,696,545: Cytomodulating Lipophilic Peptides for Modulating Immune System Activity and Inhibiting Inflammation
• U.S. Patent No. 6,900,289: Physalia Fluorescent Proteins
• U.S. Patent No. 6,667,165: Methods and Compositions for Reversible Inhibition of Thermostable Polymerases
• U.S. Patent No. 6,590,091: Nucleic Acid Sequence Detection Employing Amplification Probes
• U.S. Patent No. 6,420,523: Baculovirus produced Plasmodium falciparum Vaccine
• U.S. Patent No. 6,403,302: Methods and Compositions for Triple Helix Formation
• U.S. Patent No. 5,961,457: Method and Apparatus for Radiopharmaceutical-Guided Biopsy
• U.S. Patent Nos. 5,932,879 and 5,744,805: Solid State Beta-Sensitive Surgical Probe
• U.S. Patent No. 5,778,046: Automatic X-Ray Beam Equalizer
• U.S. Patent No. 5,671,741: Magnetic Resonance Imaging Technique for Tissue Characterization